{
  "pmid": "29712669",
  "abstract": "Proliferation-independent role of NF2 (merlin) in limiting biliary  morphogenesis.  Benhamouche-Trouillet S(1)(2)(3), O'Loughlin E(1)(2)(3), Liu CH(1)(2)(3),  Polacheck W(4), Fitamant J(1), McKee M(5), El-Bardeesy N(1), Chen CS(4),  McClatchey AI(6)(2)(3).  Author information: (1)Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, USA. (2)Harvard Medical School, Boston, MA 02114, USA. (3)Molecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129,  USA. (4)Department of Biomedical Engineering, Boston University, Wyss Institute,  Boston, MA 02115, USA. (5)Center for Systems Biology, Program in Membrane Biology, Division of  Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard  Medical School, Boston MA 02114, USA. (6)Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, USA  mcclatch@helix.mgh.harvard.edu.  The architecture of individual cells and cell collectives enables functional  specification, a prominent example being the formation of epithelial tubes that  transport fluid or gas in many organs. The intrahepatic bile ducts (IHBDs) form  a tubular network within the liver parenchyma that transports bile to the  intestine. Aberrant biliary 'neoductulogenesis' is also a feature of several  liver pathologies including tumorigenesis. However, the mechanism of biliary  tube morphogenesis in development or disease is not known. Elimination of the  neurofibromatosis type 2 protein (NF2; also known as merlin or neurofibromin 2)  causes hepatomegaly due to massive biliary neoductulogenesis in the mouse liver.  We show that this phenotype reflects unlimited biliary morphogenesis rather than  proliferative expansion. Our studies suggest that NF2 normally limits biliary  morphogenesis by coordinating lumen expansion and cell architecture. This work  provides fundamental insight into how biliary fate and tubulogenesis are  coordinated during development and will guide analyses of disease-associated and  experimentally induced biliary pathologies.  Â© 2018. Published by The Company of Biologists Ltd.  DOI: 10.1242/dev.162123 PMCID: PMC10682933 PMID: 29712669 [Indexed for MEDLINE]  Conflict of interest statement: Competing interestsThe authors declare no  competing or financial interests.",
  "methods": "",
  "introduction": "",
  "results": "",
  "discussion": "",
  "fetched_at": "2026-02-16T15:45:05.793384",
  "abstract_length": 2288,
  "methods_length": 0,
  "introduction_length": 0,
  "results_length": 0,
  "discussion_length": 0
}